Neurones: Organic growth up 10.5% in 3rd quarter 2024

PRESS INFORMATIONHeading: 3 rdquarter 2024 revenues        Nanterre, November 6, 2024 (after trading) Organic growth up 10.5% in 3 rdquarter 2024(not audited, in millions of euros)20232024growthof which organic 3 rdquarter revenues177196.7+ 11.1%+ 10.5%Total as at the end-September545.7599.1+ 9.8%+ 8.9% Achievements NEURONES posted double-digit organic growth in the 3rd quarter.The most notable advances continue to be in...
Comunicato Precedente

next
Comunicato Successivo

next
Nanterre Cedex, (informazione.it - comunicati stampa - information technology)

PRESS INFORMATION
Heading: 3rd quarter 2024 revenues        Nanterre, November 6, 2024 (after trading)

Organic growth up 10.5% in 3rd quarter 2024

(not audited, in millions of euros) 2023 2024 growth of which organic
3rd quarter revenues 177 196.7 + 11.1% + 10.5%
Total as at the end-September 545.7 599.1 + 9.8% + 8.9%

Achievements

NEURONES posted double-digit organic growth in the 3rd quarter.

The most notable advances continue to be in Data, Digital Projects, Cybersecurity, Sovereign and Secure Cloud (SecNumCloud).

Total turnover is down 3 points (14.3% vs. 17.3% a year ago).

Over the entire nine-month period, operating profit * amounted to 9.6% of revenues.

Outlook

For 2024, NEURONES confirms its forecasts made at the beginning of the year (around €800 million in revenues and 9.5% in operating profit).

* not audited and after inclusion of 0.8% of expenses related to bonus shares.

About NEURONES
With 7,100 experts, and ranking among the French leaders in consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B - NRO) – Euronext Tech Leaders – DSS mid-caps – 'PEA-PME' eligible
www.neurones.net

Press Relations:
O'Connection
Julia Philippe-Brutin
Tel.: +33 (0)6 03 63 06 03

[email protected]


NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
[email protected]
Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
[email protected]


Attachment


Per maggiori informazioni
Sito Web
neurones.fr
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Slide ShowSlide Show
Non disponibili